ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01279369
Recruitment Status : Terminated (Quantitative assessment of fFN only able to be performed at one laboratory.)
First Posted : January 19, 2011
Last Update Posted : May 7, 2018
Sponsor:
Information provided by (Responsible Party):
Wendy Kinzler, MD, Winthrop University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2012